Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick A Lewis

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
The Biochemical Journal|July 30, 2021
From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseSusanne Herbst, Patrick A Lewis
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2013
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathiesClaudia Manzoni, Patrick A Lewis
Frontiers in Psychiatry|March 23, 2011
A tangled web - tau and sporadic Parkinson's diseaseSelina Wray, Patrick A Lewis
Science Signaling|January 19, 2012
LRRK2 and human disease: a complicated question or a question of complexes?Patrick A Lewis, Claudia Manzoni
The FEBS Journal|November 22, 2008
Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2Michael J Devine, Patrick A Lewis
Brain Research Bulletin|December 17, 2011
Gene expression in the Parkinson's disease brainPatrick A Lewis, Mark R Cookson
Biochemical Society Transactions|September 20, 2012
Deciphering the function of leucine-rich repeat kinase 2 and targeting its dysfunction in diseasePatrick A Lewis, Dario R Alessi
Frontiers in Neuroscience|January 24, 2020
Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic StudiesKirsten Ebanks, Patrick A Lewis, Rina Bandopadhyay
Expert Opinion on Therapeutic Targets|June 14, 2017
Leucine Rich Repeat Kinase 2: beyond Parkinson's and beyond kinase inhibitorsSusanna Cogo, Elisa Greggio, Patrick A Lewis
Frontiers in Neuroscience|August 28, 2020
Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationMattia Volta, Patrick A Lewis, Evy Lobbestael
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
The Biochemical Journal|July 30, 2021
From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's diseaseSusanne Herbst, Patrick A Lewis
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2013
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathiesClaudia Manzoni, Patrick A Lewis
Frontiers in Psychiatry|March 23, 2011
A tangled web - tau and sporadic Parkinson's diseaseSelina Wray, Patrick A Lewis
Science Signaling|January 19, 2012
LRRK2 and human disease: a complicated question or a question of complexes?Patrick A Lewis, Claudia Manzoni
The FEBS Journal|November 22, 2008
Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2Michael J Devine, Patrick A Lewis
Brain Research Bulletin|December 17, 2011
Gene expression in the Parkinson's disease brainPatrick A Lewis, Mark R Cookson
Biochemical Society Transactions|September 20, 2012
Deciphering the function of leucine-rich repeat kinase 2 and targeting its dysfunction in diseasePatrick A Lewis, Dario R Alessi
Frontiers in Neuroscience|January 24, 2020
Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic StudiesKirsten Ebanks, Patrick A Lewis, Rina Bandopadhyay
Expert Opinion on Therapeutic Targets|June 14, 2017
Leucine Rich Repeat Kinase 2: beyond Parkinson's and beyond kinase inhibitorsSusanna Cogo, Elisa Greggio, Patrick A Lewis
Frontiers in Neuroscience|August 28, 2020
Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationMattia Volta, Patrick A Lewis, Evy Lobbestael
Pageof 12